Artiva Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $105.1M
Liabilities Breakdown FY2023
Total Liabilities: $50.7M
Asset Breakdown
Total Assets: $105.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $53.5M | 50.9% |
| Accounts Receivable | $1.0M | 1.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $8.1M | 7.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $42.5M | 40.4% |
Liabilities Breakdown
Total Liabilities: $50.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $614.0K | 1.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $50.1M | 98.8% |